EUVIMEDEUVIMED entdecken
Video/Audio

Correlation Between Androgen Receptor Expression and Prognosis in Prostate Cancer Patients: A Retrospective Study

Junyi Lu, Huiling Wu

Journal of Visualized Experiments · 30.10.2026 · (236)

DOI: 10.3791/70409 ↗

Kurz gefasst

Video/Audio in der Zeitschrift Journal of Visualized Experiments, online erschienen am 30.10.2026. Verfasst von Junyi Lu und 1 weiteren Autor:innen. Beteiligte Einrichtung: The Jinhua Affiliated Hospital of Wenzhou Medical University. Hauptthemen laut MEDLINE: Receptors, Androgen, Prostatic Neoplasms.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metastatic prostate cancer (PC) initially responds to androgen deprivation therapy (ADT) but often progresses to castration-resistant prostate cancer (CRPC). Androgen receptor (AR) expression, partly regulated by promoter-associated CpG methylation, plays a pivotal role in disease progression and therapeutic resistance. In this study, 146 formalin-fixed, paraffin-embedded (FFPE) prostate-related tissue specimens representing five disease states-non-malignant prostate tissue, primary localized PC, hormone-naïve bone metastases, short-term castration metastases, and CRPC bone metastases-were evaluated. Genome-wide promoter methylation was profiled, and AR expression was quantified at transcript and protein levels. Nuclear AR H-score (0-300) was used as the principal protein-level measure. AR H-score differed across clinical states (one-way ANOVA, F = 13.72, p < 0.001). Using the cohort median promoter-methylation beta value (0.51195) as the binary cutpoint, the distribution of low versus high methylation did not differ significantly across the five clinical groups (χ2 = 8.42, df = 4, p = 0.077), whereas continuous promoter methylation was inversely correlated with AR H-score (r = -0.480, 95% CI -0.596 to -0.344, p < 0.001). Among the 134 malignant cases included in survival analyses, the AR-high stratum showed longer observed median PFS and OS than the AR-low stratum, while the MCA Kaplan-Meier curves showed substantial overlap. Accordingly, the data support stage-related AR remodeling and an inverse AR-methylation relationship, but do not establish a simple adverse-prognostic effect of high AR expression. The MCA remains exploratory and requires independent validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, AndrogenProstatic NeoplasmsMaleHumansPrognosisRetrospective StudiesDNA MethylationBone Neoplasms

Substanzen

Receptors, Androgen

Autor:innen und Institutionen

  • The Jinhua Affiliated Hospital of Wenzhou Medical University.
  • The Jinhua Affiliated Hospital of Wenzhou Medical University; 13566782530@163.com.

Zitieren

APA

Lu, J., & Wu, H. (2026). Correlation Between Androgen Receptor Expression and Prognosis in Prostate Cancer Patients: A Retrospective Study. Journal of Visualized Experiments. https://doi.org/10.3791/70409

Vancouver

Lu J, Wu H. Correlation Between Androgen Receptor Expression and Prognosis in Prostate Cancer Patients: A Retrospective Study. Journal of Visualized Experiments. 2026. doi:10.3791/70409

BibTeX
@article{Lu2026,
  author = {Lu, Junyi and Wu, Huiling},
  title = {Correlation Between Androgen Receptor Expression and Prognosis in Prostate Cancer Patients: A Retrospective Study},
  journal = {Journal of Visualized Experiments},
  year = {2026},
  number = {236},
  doi = {10.3791/70409}
}
Kostenlos starten →